Top of this page
Skip navigation, go straight to the content

This section is intended for media and financial analysts
Newsroom Press Releases

UCB sells its food diagnostics business to Neogen

Brussels (Belgium), July 6, 2005 - UCB announces that it has signed an agreement with Neogen Corporation (NASDAQ: NEOG) to sell UCB's dairy antibiotic testing business.   These activities represent a small part of UCB's global business and are considered non-core. This divestment is therefore in line with UCB's long-term vision to build a global biopharmaceutical leader bringing to specialists first, new medicines to treat patients suffering from severe diseases.

Stay up-to-date on the latest news and information from UCB